(1->4)-beta-D-glucan multiple interactions EXP 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of OSBP2 mRNA CTD PMID:36331819 1,2-dichloroethane decreases expression EXP 6480464 ethylene dichloride results in decreased expression of OSBP2 mRNA CTD PMID:28960355 17beta-estradiol decreases expression ISO OSBP2 (Homo sapiens) 6480464 Estradiol results in decreased expression of OSBP2 mRNA CTD PMID:15223131 17beta-estradiol multiple interactions ISO OSBP2 (Homo sapiens) 6480464 [Estradiol co-treated with TGFB1 protein] results in decreased expression of OSBP2 mRNA CTD PMID:30165855 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO OSBP2 (Homo sapiens) 6480464 [Tetrachlorodibenzodioxin co-treated with 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide] results in decreased expression of OSBP2 mRNA CTD PMID:29704546 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO Osbp2 (Rattus norvegicus) 6480464 Tetrachlorodibenzodioxin results in increased expression of OSBP2 mRNA CTD PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO Osbp2 (Rattus norvegicus) 6480464 Tetrachlorodibenzodioxin results in decreased expression of OSBP2 mRNA CTD PMID:32109520 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO OSBP2 (Homo sapiens) 6480464 Tetrachlorodibenzodioxin results in decreased expression of OSBP2 mRNA CTD PMID:29704546 3,4-methylenedioxymethamphetamine increases expression EXP 6480464 N-Methyl-3 and 4-methylenedioxyamphetamine results in increased expression of OSBP2 mRNA CTD PMID:20188158 3,4-methylenedioxymethamphetamine decreases expression EXP 6480464 N-Methyl-3 and 4-methylenedioxyamphetamine results in decreased expression of OSBP2 mRNA CTD PMID:26251327 3,4-methylenedioxymethamphetamine increases methylation EXP 6480464 N-Methyl-3 and 4-methylenedioxyamphetamine results in increased methylation of OSBP2 promoter CTD PMID:26251327 4,4'-sulfonyldiphenol decreases methylation EXP 6480464 bisphenol S results in decreased methylation of OSBP2 exon CTD PMID:33297965 4,4'-sulfonyldiphenol multiple interactions ISO Osbp2 (Rattus norvegicus) 6480464 [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of OSBP2 mRNA CTD PMID:36041667 4,4'-sulfonyldiphenol affects methylation EXP 6480464 bisphenol S affects the methylation of OSBP2 gene CTD PMID:31683443 5-aza-2'-deoxycytidine affects expression ISO OSBP2 (Homo sapiens) 6480464 Decitabine affects the expression of OSBP2 mRNA CTD PMID:23300844 6-propyl-2-thiouracil decreases expression ISO Osbp2 (Rattus norvegicus) 6480464 Propylthiouracil results in decreased expression of OSBP2 mRNA CTD PMID:24780913 8-Br-cAMP decreases expression ISO OSBP2 (Homo sapiens) 6480464 8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of OSBP2 mRNA CTD PMID:22079614 acetamide increases expression ISO Osbp2 (Rattus norvegicus) 6480464 acetamide results in increased expression of OSBP2 mRNA CTD PMID:31881176 aflatoxin B1 decreases methylation ISO OSBP2 (Homo sapiens) 6480464 Aflatoxin B1 results in decreased methylation of OSBP2 intron CTD PMID:30157460 aflatoxin B1 decreases expression ISO OSBP2 (Homo sapiens) 6480464 Aflatoxin B1 results in decreased expression of OSBP2 mRNA CTD PMID:32234424 amiodarone increases expression ISO OSBP2 (Homo sapiens) 6480464 Amiodarone results in increased expression of OSBP2 mRNA CTD PMID:19774075 ammonium hexachloroplatinate affects expression ISO OSBP2 (Homo sapiens) 6480464 ammonium hexachloroplatinate affects the expression of OSBP2 mRNA CTD PMID:19527780 aristolochic acid A increases expression ISO OSBP2 (Homo sapiens) 6480464 aristolochic acid I results in increased expression of OSBP2 mRNA CTD PMID:33212167 benzo[a]pyrene decreases expression ISO OSBP2 (Homo sapiens) 6480464 Benzo(a)pyrene results in decreased expression of OSBP2 mRNA CTD PMID:21871943 benzo[a]pyrene affects methylation ISO OSBP2 (Homo sapiens) 6480464 Benzo(a)pyrene affects the methylation of OSBP2 promoter CTD PMID:27901495 benzo[a]pyrene increases methylation ISO OSBP2 (Homo sapiens) 6480464 Benzo(a)pyrene results in increased methylation of OSBP2 exon CTD PMID:27901495 benzo[a]pyrene diol epoxide I decreases expression ISO OSBP2 (Homo sapiens) 6480464 7 more ... CTD PMID:19150397 benzo[e]pyrene decreases methylation ISO OSBP2 (Homo sapiens) 6480464 benzo(e)pyrene results in decreased methylation of OSBP2 intron CTD PMID:30157460 bis(2-ethylhexyl) phthalate decreases expression ISO OSBP2 (Homo sapiens) 6480464 Diethylhexyl Phthalate results in decreased expression of OSBP2 mRNA CTD PMID:31163220 bisphenol A decreases expression ISO OSBP2 (Homo sapiens) 6480464 bisphenol A results in decreased expression of OSBP2 mRNA CTD PMID:15223131 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of OSBP2 mRNA CTD PMID:32156529 bisphenol A multiple interactions ISO Osbp2 (Rattus norvegicus) 6480464 [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of OSBP2 mRNA CTD PMID:36041667 bisphenol A decreases methylation ISO OSBP2 (Homo sapiens) 6480464 bisphenol A results in decreased methylation of OSBP2 gene CTD PMID:31601247 bisphenol A multiple interactions ISO OSBP2 (Homo sapiens) 6480464 [bisphenol A co-treated with Fulvestrant] results in decreased methylation of OSBP2 gene CTD PMID:31601247 bisphenol A decreases expression ISO Osbp2 (Rattus norvegicus) 6480464 bisphenol A results in decreased expression of OSBP2 mRNA CTD PMID:25181051 and PMID:34947998 bisphenol F multiple interactions ISO Osbp2 (Rattus norvegicus) 6480464 [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of OSBP2 mRNA CTD PMID:36041667 Brodifacoum decreases expression ISO Osbp2 (Rattus norvegicus) 6480464 bromfenacoum results in decreased expression of OSBP2 protein CTD PMID:28903499 bromobenzene increases expression ISO Osbp2 (Rattus norvegicus) 6480464 bromobenzene results in increased expression of OSBP2 mRNA CTD PMID:32479839 C60 fullerene decreases expression ISO Osbp2 (Rattus norvegicus) 6480464 fullerene C60 results in decreased expression of OSBP2 mRNA CTD PMID:19167457 cannabidiol increases expression ISO OSBP2 (Homo sapiens) 6480464 Cannabidiol results in increased expression of OSBP2 mRNA CTD PMID:33244087 carbon nanotube decreases expression EXP 6480464 Nanotubes and Carbon results in decreased expression of OSBP2 mRNA CTD PMID:25620056 chlorpyrifos increases expression EXP 6480464 Chlorpyrifos results in increased expression of OSBP2 mRNA CTD PMID:37019170 choline multiple interactions EXP 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of OSBP2 gene CTD PMID:20938992 cisplatin affects expression ISO OSBP2 (Homo sapiens) 6480464 Cisplatin affects the expression of OSBP2 mRNA CTD PMID:23300844 cisplatin multiple interactions ISO OSBP2 (Homo sapiens) 6480464 [Cisplatin co-treated with jinfukang] results in decreased expression of OSBP2 mRNA CTD PMID:27392435 copper atom increases expression ISO Osbp2 (Rattus norvegicus) 6480464 Copper deficiency results in increased expression of OSBP2 mRNA CTD PMID:26033743 copper(0) increases expression ISO Osbp2 (Rattus norvegicus) 6480464 Copper deficiency results in increased expression of OSBP2 mRNA CTD PMID:26033743 crocidolite asbestos increases expression EXP 6480464 Asbestos and Crocidolite results in increased expression of OSBP2 mRNA CTD PMID:29279043 dorsomorphin multiple interactions ISO OSBP2 (Homo sapiens) 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of OSBP2 mRNA CTD PMID:27188386 doxorubicin decreases expression ISO OSBP2 (Homo sapiens) 6480464 Doxorubicin results in decreased expression of OSBP2 mRNA CTD PMID:29803840 elemental selenium increases expression ISO OSBP2 (Homo sapiens) 6480464 Selenium results in increased expression of OSBP2 mRNA CTD PMID:19244175 endosulfan increases expression ISO Osbp2 (Rattus norvegicus) 6480464 Endosulfan results in increased expression of OSBP2 mRNA CTD PMID:29391264 ethanol affects splicing EXP 6480464 Ethanol affects the splicing of OSBP2 mRNA CTD PMID:30319688 folic acid multiple interactions EXP 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of OSBP2 gene CTD PMID:20938992 fulvestrant multiple interactions ISO OSBP2 (Homo sapiens) 6480464 [bisphenol A co-treated with Fulvestrant] results in decreased methylation of OSBP2 gene CTD PMID:31601247 gentamycin increases expression ISO Osbp2 (Rattus norvegicus) 6480464 Gentamicins results in increased expression of OSBP2 mRNA CTD PMID:33387578 hexamethylene diisocyanate affects expression ISO OSBP2 (Homo sapiens) 6480464 1 and 6-hexamethylene diisocyanate affects the expression of OSBP2 mRNA CTD PMID:19527780 hydroquinone O-beta-D-glucopyranoside decreases expression ISO OSBP2 (Homo sapiens) 6480464 Arbutin results in decreased expression of OSBP2 mRNA CTD PMID:17103032 kojic acid decreases expression ISO OSBP2 (Homo sapiens) 6480464 kojic acid results in decreased expression of OSBP2 mRNA CTD PMID:16595896 L-methionine multiple interactions EXP 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of OSBP2 gene CTD PMID:20938992 lipopolysaccharide multiple interactions ISO OSBP2 (Homo sapiens) 6480464 [S-(1 more ... CTD PMID:35811015 methapyrilene decreases methylation ISO OSBP2 (Homo sapiens) 6480464 Methapyrilene results in decreased methylation of OSBP2 intron CTD PMID:30157460 N,N-diethyl-m-toluamide multiple interactions ISO Osbp2 (Rattus norvegicus) 6480464 [Permethrin co-treated with DEET] results in decreased methylation of OSBP2 gene CTD PMID:33148267 N-ethyl-N-nitrosourea increases mutagenesis EXP 6480464 Ethylnitrosourea results in increased mutagenesis of OSBP2 mRNA CTD PMID:27776689 O-methyleugenol decreases expression ISO OSBP2 (Homo sapiens) 6480464 methyleugenol results in decreased expression of OSBP2 mRNA CTD PMID:32234424 paracetamol decreases expression ISO OSBP2 (Homo sapiens) 6480464 Acetaminophen results in decreased expression of OSBP2 mRNA CTD PMID:22230336 and PMID:26690555 paracetamol increases expression ISO Osbp2 (Rattus norvegicus) 6480464 Acetaminophen results in increased expression of OSBP2 mRNA CTD PMID:33387578 paracetamol increases expression ISO OSBP2 (Homo sapiens) 6480464 Acetaminophen results in increased expression of OSBP2 mRNA CTD PMID:29067470 perfluorooctane-1-sulfonic acid multiple interactions EXP 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of OSBP2 mRNA CTD PMID:36331819 permethrin multiple interactions ISO Osbp2 (Rattus norvegicus) 6480464 [Permethrin co-treated with DEET] results in decreased methylation of OSBP2 gene CTD PMID:33148267 S-(1,2-dichlorovinyl)-L-cysteine multiple interactions ISO OSBP2 (Homo sapiens) 6480464 [S-(1 more ... CTD PMID:35811015 SB 431542 multiple interactions ISO OSBP2 (Homo sapiens) 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of OSBP2 mRNA CTD PMID:27188386 selenium atom increases expression ISO OSBP2 (Homo sapiens) 6480464 Selenium results in increased expression of OSBP2 mRNA CTD PMID:19244175 silicon dioxide increases expression ISO OSBP2 (Homo sapiens) 6480464 Silicon Dioxide analog results in increased expression of OSBP2 mRNA CTD PMID:25895662 silicon dioxide increases expression EXP 6480464 Silicon Dioxide results in increased expression of OSBP2 mRNA CTD PMID:29203145 sodium arsenite affects methylation ISO OSBP2 (Homo sapiens) 6480464 sodium arsenite affects the methylation of OSBP2 gene CTD PMID:28589171 sodium arsenite decreases expression EXP 6480464 sodium arsenite results in decreased expression of OSBP2 mRNA CTD PMID:36209798 sodium arsenite decreases expression ISO OSBP2 (Homo sapiens) 6480464 sodium arsenite results in decreased expression of OSBP2 mRNA CTD PMID:34032870 Soman increases expression ISO Osbp2 (Rattus norvegicus) 6480464 Soman results in increased expression of OSBP2 mRNA CTD PMID:19281266 sulforaphane decreases expression ISO OSBP2 (Homo sapiens) 6480464 sulforaphane results in decreased expression of OSBP2 mRNA CTD PMID:31838189 trichloroethene increases expression ISO Osbp2 (Rattus norvegicus) 6480464 Trichloroethylene results in increased expression of OSBP2 mRNA CTD PMID:33387578 trichostatin A decreases expression ISO OSBP2 (Homo sapiens) 6480464 trichostatin A results in decreased expression of OSBP2 mRNA CTD PMID:24935251 trimellitic anhydride affects expression ISO OSBP2 (Homo sapiens) 6480464 trimellitic anhydride affects the expression of OSBP2 mRNA CTD PMID:19527780 triptonide increases expression EXP 6480464 triptonide results in increased expression of OSBP2 mRNA CTD PMID:33045310 tris(2-butoxyethyl) phosphate affects expression ISO OSBP2 (Homo sapiens) 6480464 tris(2-butoxyethyl) phosphate affects the expression of OSBP2 mRNA CTD PMID:29024780 valproic acid decreases expression ISO OSBP2 (Homo sapiens) 6480464 Valproic Acid results in decreased expression of OSBP2 mRNA CTD PMID:23179753 and PMID:26272509 valproic acid multiple interactions ISO OSBP2 (Homo sapiens) 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of OSBP2 mRNA CTD PMID:27188386 vinclozolin affects expression ISO Osbp2 (Rattus norvegicus) 6480464 vinclozolin affects the expression of OSBP2 mRNA CTD PMID:19015723